Revvity Debt to Equity Ratio 2010-2024 | RVTY

Current and historical debt to equity ratio values for Revvity (RVTY) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Revvity debt/equity for the three months ending March 31, 2024 was 0.40.
Revvity Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-03-31 $5.59B $7.85B 0.71
2023-12-31 $5.69B $7.87B 0.72
2023-09-30 $5.73B $7.69B 0.74
2023-06-30 $6.35B $7.87B 0.81
2023-03-31 $6.60B $8.03B 0.82
2022-12-31 $6.75B $7.38B 0.91
2022-09-30 $6.76B $7.07B 0.96
2022-06-30 $7.02B $7.17B 0.98
2022-03-31 $7.66B $7.19B 1.07
2021-12-31 $7.86B $7.14B 1.10
2021-09-30 $7.94B $6.96B 1.14
2021-06-30 $4.50B $4.24B 1.06
2021-03-31 $4.76B $4.00B 1.19
2020-12-31 $4.23B $3.74B 1.13
2020-09-30 $3.63B $3.23B 1.12
2020-06-30 $3.67B $2.97B 1.24
2020-03-31 $3.63B $2.76B 1.31
2019-12-31 $3.73B $2.81B 1.32
2019-09-30 $3.78B $2.71B 1.40
2019-06-30 $3.69B $2.71B 1.36
2019-03-31 $3.45B $2.64B 1.31
2018-12-31 $3.39B $2.59B 1.31
2018-09-30 $3.29B $2.57B 1.28
2018-06-30 $3.44B $2.52B 1.37
2018-03-31 $3.57B $2.56B 1.40
2017-12-31 $3.59B $2.50B 1.43
2017-09-30 $2.20B $2.54B 0.87
2017-06-30 $2.17B $2.44B 0.89
2017-03-31 $2.13B $2.21B 0.97
2016-12-31 $2.12B $2.15B 0.99
2016-09-30 $2.17B $2.14B 1.02
2016-06-30 $2.11B $2.09B 1.01
2016-03-31 $2.16B $2.05B 1.06
2015-12-31 $2.06B $2.11B 0.97
2015-09-30 $1.98B $2.05B 0.96
2015-06-30 $1.96B $2.12B 0.93
2015-03-31 $1.97B $2.06B 0.96
2014-12-31 $2.09B $2.04B 1.02
2014-09-30 $1.82B $2.06B 0.88
2014-06-30 $1.88B $2.06B 0.92
2014-03-31 $1.94B $2.03B 0.96
2013-12-31 $1.95B $1.99B 0.98
2013-09-30 $1.93B $1.92B 1.01
2013-06-30 $1.95B $1.86B 1.05
2013-03-31 $1.97B $1.83B 1.08
2012-12-31 $1.96B $1.94B 1.01
2012-09-30 $1.95B $1.94B 1.00
2012-06-30 $1.92B $1.89B 1.02
2012-03-31 $1.98B $1.88B 1.05
2011-12-31 $2.01B $1.84B 1.09
2011-09-30 $1.46B $1.95B 0.75
2011-06-30 $1.64B $1.96B 0.84
2011-03-31 $1.40B $1.91B 0.73
2010-12-31 $1.28B $1.93B 0.67
2010-09-30 $1.54B $1.71B 0.90
2010-06-30 $1.50B $1.64B 0.91
2010-03-31 $1.40B $1.63B 0.86
2009-12-31 $1.43B $1.63B 0.88
2009-09-30 $1.46B $1.60B 0.91
2009-06-30 $1.37B $1.57B 0.87
2009-03-31 $1.35B $1.51B 0.89
Sector Industry Market Cap Revenue
Medical Medical Services $13.345B $2.751B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $115.971B 14.14
Cencora (COR) United States $44.597B 17.39
ICON (ICLR) Ireland $27.199B 25.68
DiDi Global (DIDIY) China $17.303B 0.00
Avantor (AVTR) United States $14.163B 20.85
CochLear (CHEOY) Australia $14.103B 0.00
Viatris (VTRS) United States $14.098B 4.21
Medpace Holdings (MEDP) United States $13.053B 42.95
Natera (NTRA) United States $13.015B 0.00
Charles River Laboratories (CRL) United States $11.242B 21.52
Solventum (SOLV) United States $9.430B 0.00
Sonic Healthcare (SKHHY) Australia $8.373B 0.00
HealthEquity (HQY) United States $6.385B 40.99
Bausch + Lomb (BLCO) Canada $5.974B 23.92
Organon (OGN) United States $5.395B 5.12
Doximity (DOCS) United States $5.233B 36.65
PACS (PACS) United States $4.921B 0.00
Life Times (LTH) United States $4.146B 43.44
Sotera Health (SHC) United States $3.705B 18.18
Surgery Partners (SGRY) United States $3.692B 33.78
GoodRx Holdings (GDRX) United States $3.189B 121.43
Agilon Health (AGL) United States $2.834B 0.00
Progyny (PGNY) United States $2.646B 45.56
AMN Healthcare Services Inc (AMN) United States $2.167B 8.59
Premier (PINC) United States $2.051B 8.78
BrightSpring Health Services (BTSG) United States $2.004B 0.00
Alignment Healthcare (ALHC) United States $1.925B 0.00
Teladoc Health (TDOC) United States $1.542B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.467B 0.00
Establishment Labs Holdings (ESTA) $1.251B 0.00
CareDx (CDNA) United States $0.942B 0.00
GeneDx Holdings (WGS) United States $0.831B 0.00
InnovAge Holding (INNV) United States $0.825B 0.00
Embecta (EMBC) United States $0.760B 5.16
Auna S.A (AUNA) Luxembourg $0.657B 0.00
Pediatrix Medical (MD) United States $0.633B 6.71
COMPASS Pathways (CMPS) United Kingdom $0.499B 0.00
Sharecare (SHCR) United States $0.497B 0.00
Enhabit (EHAB) United States $0.476B 47.45
Sonida Senior Living (SNDA) United States $0.407B 0.00
QDM (QDMI) Hong Kong, SAR China $0.353B 9.24
ModivCare (MODV) United States $0.335B 6.27
DocGo (DCGO) United States $0.314B 17.17
LifeMD (LFMD) United States $0.274B 0.00
MultiPlan (MPLN) United States $0.258B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
Beauty Health (SKIN) United States $0.221B 0.00
Biodesix (BDSX) United States $0.203B 0.00
Ascend Wellness Holdings (AAWH) United States $0.194B 0.00
So-Young (SY) China $0.100B 48.51
Pono Capital Two (PTWO) United States $0.068B 0.00
NeueHealth (NEUE) United States $0.043B 5.82
Co-Diagnostics (CODX) United States $0.041B 0.00
Oncology Institute (TOI) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.034B 0.00
Nutex Health (NUTX) United States $0.034B 0.00
OncoCyte (OCX) United States $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.024B 0.00
SeaStar Medical Holding (ICU) United States $0.024B 0.00
TRxADE HEALTH (MEDS) United States $0.021B 0.00
Singular Genomics Systems (OMIC) United States $0.020B 0.00
KindlyMD (KDLY) $0.017B 0.00
BIMI Holdings (BIMI) United States $0.016B 0.00
BioNexus Gene Lab (BGLC) $0.009B 0.00
XWELL (XWEL) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.005B 0.00
OpGen (OPGN) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Singapore $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Assure Holdings (IONM) United States $0.002B 0.00